Document Detail


Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine.
MedLine Citation:
PMID:  8669108     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prostaglandin (PG) E1 administered intravenously has been used for the treatment of primary nonfunction of hepatic allografts and fulminant hepatic failure. It has been proposed that this therapy may improve hepatic blood flow via the vasodilating properties of PGE1. However, PGE1 undergoes extensive metabolic inactivation by the lung and the concentration of PGE1 reaching the liver during intravenous administration has not been determined. Thus, we measured plasma PGE1 concentrations in patients with hepatic dysfunction being treated with PGE1 and in a swine model of PGE1 infusion. We also determined the hemodynamic effects of PGE1 infusion in swine. Blood was sampled from the pulmonary artery, carotid artery, portal vein, and hepatic vein in swine infused with PGE1 (range, 0.67-4.9 microg/kg/hr) demonstrating: (1) a pulmonary extraction ratio of PGE1 of 0.78 +/- 0.12, (2) a splanchnic extraction ratio of PGE1 of 0.54 +/- 0.23, and (3) levels of PGE1 in the systemic circulation of </= 78 pg/ml, even at the highest infusion rates. Despite significant increases in body temperature and pulse rate, hepatic hemodynamics were not affected by the PGE1 infusions in healthy swine. Seven patients receiving intravenous PGE1 for hepatic dysfunction (0.11-1.30 microg/kg/hr) had a pulmonary extraction ratio of 0.69 +/- 0.17. Systemic arterial concentrations of PGE1 were </= 62 pg/ml. These results suggest that due to clearance of PGE2 in the pulmonary and splanchnic circulations, current clinical protocols for intravenous administration of PGE1 are not likely to affect perihepatic hemodynamics.
Authors:
J A Awas; M C Soteriou; J G Drougas; K A Stokes; L J Roberts; C W Pinson
Related Documents :
2090188 - Severe juxtahepatic venous injury: survival after prolonged hepatic vascular isolation ...
3715718 - Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications...
1878748 - Adenosine-induced dilatation of the rabbit hepatic arterial bed is mediated by a2-purin...
9638438 - Left hepatic vein kinking after right trisegmentectomy: a potential cause of postoperat...
23482898 - Transvenous proximal closure of large congenital coronary arteriovenous fistula using t...
22904198 - The nox4 inhibitor gkt137831 attenuates hypoxia-induced pulmonary vascular cell prolife...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Transplantation     Volume:  61     ISSN:  0041-1337     ISO Abbreviation:  Transplantation     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-08-02     Completed Date:  1996-08-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1624-9     Citation Subset:  IM    
Affiliation:
Department of Medicine , Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alprostadil / administration & dosage,  blood*,  pharmacology*
Animals
Female
Hemodynamics / drug effects*
Humans
Infusions, Intravenous
Male
Middle Aged
Swine
Grant Support
ID/Acronym/Agency:
GM 15431/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
745-65-3/Alprostadil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine...
Next Document:  Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochim...